Heartflow (HTFL) Long-Term Investments (2025 - 2026)
Heartflow (HTFL) posted Long-Term Investments of $84.3 million for Q2 2026, down 18.45% on a QoQ basis from $103.4 million in Q4 2025.
Powered by 
Analysis
Heartflow (HTFL) Long-Term Investments (2025 - 2026) Analysis & Trends
Heartflow has reported Long-Term Investments for 2 years, with the latest figure at $84.3 million in Q2 2026.
- On a quarterly basis, Long-Term Investments changed N/A year-over-year to $84.3 million in Q2 2026; TTM through Jun 2026 was $84.3 million, a N/A change from a year earlier, with the FY2025 full-year figure at $103.4 million, changed N/A from the prior year.
- Long-Term Investments was $84.3 million for Q2 2026 at Heartflow, down from $103.4 million in the prior quarter.
- The five-year high for Long-Term Investments was $103.4 million in Q4 2025, with the low at $84.3 million in Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 31.10 Bn | 29.22 Bn | 2.18 Bn | - |
| 2 | Lantheus Holdings | 6.59 Bn | 6.00 Bn | 241.86 Mn | 118.98 Mn |
| 3 | Heartflow | 4.24 Bn | 3.87 Bn | 53.19 Mn | 84.29 Mn |
| 4 | Neogen | 2.58 Bn | 2.39 Bn | 107.80 Mn | - |
| 5 | Butterfly Network | 1.75 Bn | 1.62 Bn | 23.29 Mn | - |
| 6 | QuidelOrtho | 954.15 Mn | 830.75 Mn | - | - |
| 7 | Ceribell | 944.88 Mn | 815.62 Mn | 25.94 Mn | - |
| 8 | Anbio Biotechnology | 941.05 Mn | 929.15 Mn | - | - |
| 9 | Varex Imaging | 780.16 Mn | 694.86 Mn | 76.70 Mn | 20.20 Mn |
| 10 | Prenetics Global | 357.49 Mn | 298.35 Mn | 30.20 Mn | - |